BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 12426945)

  • 1. pH-sensitive liposomes: mechanism of triggered release to drug and gene delivery prospects.
    Venugopalan P; Jain S; Sankar S; Singh P; Rawat A; Vyas SP
    Pharmazie; 2002 Oct; 57(10):659-71. PubMed ID: 12426945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "Smart" delivery of antisense oligonucleotides by anionic pH-sensitive liposomes.
    Fattal E; Couvreur P; Dubernet C
    Adv Drug Deliv Rev; 2004 Apr; 56(7):931-46. PubMed ID: 15066753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Entrapment of small molecules and nucleic acid-based drugs in liposomes.
    Fenske DB; Cullis PR
    Methods Enzymol; 2005; 391():7-40. PubMed ID: 15721372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of pH-sensitive liposomes that efficiently retain encapsulated doxorubicin (DXR) in blood.
    Ishida T; Okada Y; Kobayashi T; Kiwada H
    Int J Pharm; 2006 Feb; 309(1-2):94-100. PubMed ID: 16364578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. pH-sensitive liposomes--principle and application in cancer therapy.
    Karanth H; Murthy RS
    J Pharm Pharmacol; 2007 Apr; 59(4):469-83. PubMed ID: 17430630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The inhibitory effects of hepatocyte targeting pH-sensitive liposome mediated phosphorothioate antisense oligonucleotide on gene expression controlled by HCV 5'NCR].
    Wang XH; Wang SQ; Wen SY; Guan W; Mao BZ
    Sheng Wu Gong Cheng Xue Bao; 2001 Nov; 17(6):626-30. PubMed ID: 11910753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. pH-sensitive liposomes for drug delivery in cancer treatment.
    Ferreira Ddos S; Lopes SC; Franco MS; Oliveira MC
    Ther Deliv; 2013 Sep; 4(9):1099-123. PubMed ID: 24024511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alkylated derivatives of poly(ethylacrylic acid) can be inserted into preformed liposomes and trigger pH-dependent intracellular delivery of liposomal contents.
    Chen T; McIntosh D; He Y; Kim J; Tirrell DA; Scherrer P; Fenske DB; Sandhu AP; Cullis PR
    Mol Membr Biol; 2004; 21(6):385-93. PubMed ID: 15764368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liposomes incorporating hydrophobically modified silk fibroin: pH-dependent release.
    Hong YJ; Pyo CG; Kim JC
    Int J Biol Macromol; 2010 Dec; 47(5):635-9. PubMed ID: 20728469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-circulating, pH-sensitive liposomes sterically stabilized by copolymers bearing short blocks of lipid-mimetic units.
    Momekova D; Rangelov S; Yanev S; Nikolova E; Konstantinov S; Romberg B; Storm G; Lambov N
    Eur J Pharm Sci; 2007 Dec; 32(4-5):308-17. PubMed ID: 17928206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytosolic delivery of macromolecules. 3. Synthesis and characterization of acid-sensitive bis-detergents.
    Asokan A; Cho MJ
    Bioconjug Chem; 2004; 15(6):1166-73. PubMed ID: 15546181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liposomal antisense oligonucleotides for cancer therapy.
    Siwak DR; Tari AM; Lopez-Berestein G
    Methods Enzymol; 2004; 387():241-53. PubMed ID: 15172168
    [No Abstract]   [Full Text] [Related]  

  • 13. Transferrin-modified liposomes equipped with a pH-sensitive fusogenic peptide: an artificial viral-like delivery system.
    Kakudo T; Chaki S; Futaki S; Nakase I; Akaji K; Kawakami T; Maruyama K; Kamiya H; Harashima H
    Biochemistry; 2004 May; 43(19):5618-28. PubMed ID: 15134436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemical approaches to triggerable lipid vesicles for drug and gene delivery.
    Guo X; Szoka FC
    Acc Chem Res; 2003 May; 36(5):335-41. PubMed ID: 12755643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liposomal cargo unloading induced by pH-sensitive peptides.
    Lee HM; Chmielewski J
    J Pept Res; 2005 Mar; 65(3):355-63. PubMed ID: 15787966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors affecting drug release from liposomes.
    Lindner LH; Hossann M
    Curr Opin Drug Discov Devel; 2010 Jan; 13(1):111-23. PubMed ID: 20047152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of dioleoylphosphatidylethanolamine (DOPE) in targeted gene delivery with mannosylated cationic liposomes via intravenous route.
    Hattori Y; Suzuki S; Kawakami S; Yamashita F; Hashida M
    J Control Release; 2005 Nov; 108(2-3):484-95. PubMed ID: 16181701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytosolic delivery of macromolecules 4. Head group-dependent membrane permeabilization by pH-sensitive detergents.
    Asokan A; Cho MJ
    J Control Release; 2005 Aug; 106(1-2):146-53. PubMed ID: 15979190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 'Smart' delivery systems for biomolecular therapeutics.
    Stayton PS; El-Sayed ME; Murthy N; Bulmus V; Lackey C; Cheung C; Hoffman AS
    Orthod Craniofac Res; 2005 Aug; 8(3):219-25. PubMed ID: 16022724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.